Member_News
ADRAG · June 9, 2024
By Chris Nakea In a heartfelt narrative, Karrie Hughes-Kay shares her deeply personal journey with her mother, Jutta Glavind, and their family’s long battle with Alzheimer’s disease. This poignant […]
Read More
Member_News
ADRAG · June 9, 2024
By Chris Nakea In a follow-up to our previous article, Karrie Hughes-Kay continues to share the evolving story of her mother, Jutta Glavind, and their journey with the Alzheimer’s […]
Read More
News & Updates
ADRAG · June 7, 2024
UC Berkeley scientists have made a significant breakthrough in understanding how stress responses in brain cells can be turned off, a discovery that could pave the way for new treatments […]
Read More
News & Updates
ADRAG · June 7, 2024
The Alzheimer’s drug development pipeline for 2024 is bustling with activity, featuring 171 ongoing studies and 134 drugs in clinical trials. Notable treatments in the pipeline include donanemab and the […]
Read More
News & Updates
ADRAG · June 7, 2024
Researchers at Ruhr-University Bochum have developed a groundbreaking group training tool aimed at preventing dementia. This innovative tool focuses on cognitive training and lifestyle changes to help reduce the risk […]
Read More
Other
ADRAG · June 7, 2024
June is Alzheimer’s & Brain Awareness Month, a crucial time dedicated to raising awareness about Alzheimer’s disease and promoting brain health. This year’s campaign focuses on empowering Americans to take […]
Read More
Other
ADRAG · April 5, 2024
The entertainment industry has recently faced the poignant loss of one of its most beloved figures, Steve Lawrence, who passed away at the age of 88 due to complications linked […]
Read More
Other
ADRAG · April 5, 2024
In the realm of neurological research, a groundbreaking study has cast light on the intricate interplay between our personality traits and the likelihood of developing dementia. Sponsored by the National […]
Read More
Other
ADRAG · March 19, 2024
CHICAGO, March 15, 2024 – The Alzheimer’s Association has released a pivotal report, shedding light on the critical gap in communication between patients experiencing cognitive concerns and their healthcare providers. […]
Read More
Other
ADRAG · March 19, 2024
In a groundbreaking advancement for the medical community, scientists have developed innovative tools designed to identify patients with potentially treatable forms of rapidly progressive dementia. This significant development, announced on […]
Read More
Other
ADRAG · March 7, 2024
The global impact of Alzheimer’s and other forms of dementia is both profound and escalating. Currently, over 55 million people worldwide are living with dementia, a number that is projected […]
Read More
News & Updates
ADRAG · February 21, 2024
Biogen has announced the discontinuation of Aduhelm, its first Alzheimer’s treatment, to reallocate resources towards Leqembi, a newer drug that has shown promise in slowing the progression of the disease. […]
Read MoreStay connected
News, ideas, and opportunities from the ADRAG community.